Markets
News
Analysis
User
24/7
Economic Calendar
Education
Data
- Names
- Latest
- Prev












Signal Accounts for Members
All Signal Accounts
All Contests



U.K. Trade Balance Non-EU (SA) (Oct)A:--
F: --
P: --
U.K. Trade Balance (Oct)A:--
F: --
P: --
U.K. Services Index MoMA:--
F: --
P: --
U.K. Construction Output MoM (SA) (Oct)A:--
F: --
P: --
U.K. Industrial Output YoY (Oct)A:--
F: --
P: --
U.K. Trade Balance (SA) (Oct)A:--
F: --
P: --
U.K. Trade Balance EU (SA) (Oct)A:--
F: --
P: --
U.K. Manufacturing Output YoY (Oct)A:--
F: --
P: --
U.K. GDP MoM (Oct)A:--
F: --
P: --
U.K. GDP YoY (SA) (Oct)A:--
F: --
P: --
U.K. Industrial Output MoM (Oct)A:--
F: --
P: --
U.K. Construction Output YoY (Oct)A:--
F: --
P: --
France HICP Final MoM (Nov)A:--
F: --
P: --
China, Mainland Outstanding Loans Growth YoY (Nov)A:--
F: --
P: --
China, Mainland M2 Money Supply YoY (Nov)A:--
F: --
P: --
China, Mainland M0 Money Supply YoY (Nov)A:--
F: --
P: --
China, Mainland M1 Money Supply YoY (Nov)A:--
F: --
P: --
India CPI YoY (Nov)A:--
F: --
P: --
India Deposit Gowth YoYA:--
F: --
P: --
Brazil Services Growth YoY (Oct)A:--
F: --
P: --
Mexico Industrial Output YoY (Oct)A:--
F: --
P: --
Russia Trade Balance (Oct)A:--
F: --
P: --
Philadelphia Fed President Henry Paulson delivers a speech
Canada Building Permits MoM (SA) (Oct)A:--
F: --
P: --
Canada Wholesale Sales YoY (Oct)A:--
F: --
P: --
Canada Wholesale Inventory MoM (Oct)A:--
F: --
P: --
Canada Wholesale Inventory YoY (Oct)A:--
F: --
P: --
Canada Wholesale Sales MoM (SA) (Oct)A:--
F: --
P: --
Germany Current Account (Not SA) (Oct)A:--
F: --
P: --
U.S. Weekly Total Rig CountA:--
F: --
P: --
U.S. Weekly Total Oil Rig CountA:--
F: --
P: --
Japan Tankan Large Non-Manufacturing Diffusion Index (Q4)--
F: --
P: --
Japan Tankan Small Manufacturing Outlook Index (Q4)--
F: --
P: --
Japan Tankan Large Non-Manufacturing Outlook Index (Q4)--
F: --
P: --
Japan Tankan Large Manufacturing Outlook Index (Q4)--
F: --
P: --
Japan Tankan Small Manufacturing Diffusion Index (Q4)--
F: --
P: --
Japan Tankan Large Manufacturing Diffusion Index (Q4)--
F: --
P: --
Japan Tankan Large-Enterprise Capital Expenditure YoY (Q4)--
F: --
P: --
U.K. Rightmove House Price Index YoY (Dec)--
F: --
P: --
China, Mainland Industrial Output YoY (YTD) (Nov)--
F: --
P: --
China, Mainland Urban Area Unemployment Rate (Nov)--
F: --
P: --
Saudi Arabia CPI YoY (Nov)--
F: --
P: --
Euro Zone Industrial Output YoY (Oct)--
F: --
P: --
Euro Zone Industrial Output MoM (Oct)--
F: --
P: --
Canada Existing Home Sales MoM (Nov)--
F: --
P: --
Euro Zone Total Reserve Assets (Nov)--
F: --
P: --
U.K. Inflation Rate Expectations--
F: --
P: --
Canada National Economic Confidence Index--
F: --
P: --
Canada New Housing Starts (Nov)--
F: --
P: --
U.S. NY Fed Manufacturing Employment Index (Dec)--
F: --
P: --
U.S. NY Fed Manufacturing Index (Dec)--
F: --
P: --
Canada Core CPI YoY (Nov)--
F: --
P: --
Canada Manufacturing Unfilled Orders MoM (Oct)--
F: --
P: --
Canada Manufacturing New Orders MoM (Oct)--
F: --
P: --
Canada Core CPI MoM (Nov)--
F: --
P: --
Canada Manufacturing Inventory MoM (Oct)--
F: --
P: --
Canada CPI YoY (Nov)--
F: --
P: --
Canada CPI MoM (Nov)--
F: --
P: --
Canada CPI YoY (SA) (Nov)--
F: --
P: --
Canada Core CPI MoM (SA) (Nov)--
F: --
P: --


No matching data
Latest Views
Latest Views
Trending Topics
Top Columnists
Latest Update
White Label
Data API
Web Plug-ins
Affiliate Program
View All

No data
Tenon Medical Inc shares are trading higher by 49% to $1.27 Friday morning after the company announced it has successfully passed a recent FDA Quality System Inspection Technique (QSIT) Level 2 Inspection.
This inspection assesses compliance with Quality System Requirements and related regulations for medical device manufacturers. The FDA inspector found no violations or objectionable conditions during the inspection, and no FDA Form 483 was issued.
Tenon Medical's CEO, Steve Foster, commended the company's dedication to maintaining a high-quality system and recognized their operational and regulatory teams for their diligence.
See Also: Former FTX CEO Sam Bankman-Fried Found Guilty On All Criminal Fraud Charges
According to data from Benzinga Pro, TNON has a 52-week high of $31.10 and a 52-week low of $0.77.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Health care stocks rose late Wednesday afternoon with the NYSE Health Care Index up 0.3% and the Health Care Select Sector SPDR Fund (XLV) gaining 0.4%.
The iShares Biotechnology ETF (IBB) rose 1.4%.
In corporate news, Aldeyra Therapeutics shares soared 47% after the company said it signed an exclusive option agreement with AbbVie (ABBV) to acquire separate licenses to develop, manufacture and commercialize reproxalap in and outside the US.
Silence Therapeutics (SLN) jumped 28%. The company reported "positive" topline results from the multiple dose component of the phase 1 study of zerlasiran in 36 adults with high baseline lipoprotein(a) levels and stable atherosclerotic cardiovascular disease.
Tenon Medical shares slumped 39% after the company said it will implement a 1-for-10 reverse stock split to regain compliance with Nasdaq's minimum closing price requirement for continued listing.
BioSig Technologies shares surged 33% after the company said the US Patent and Trademark Office awarded five new utility patents covering its digital signal processing technology.
Health care stocks were lower Wednesday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each down around 0.1%.
The iShares Biotechnology ETF (IBB) rose 0.4%.
In company news, Tenon Medical (c) shares slumped about 24% after the company said it will implement a 1-for-10 reverse stock split to regain compliance with Nasdaq's minimum closing price requirement for continued listing.
BioSig Technologies surged 35% after it said Wednesday that the US Patent and Trademark Office has awarded five new utility patents covering its digital signal processing technology.
Sotera Health gained almost 13% after the company reported Q3 adjusted earnings of $0.21 per diluted share, down from $0.23 a year earlier. Analysts polled by Capital IQ expected $0.20.
Tenon Medical said Wednesday it will implement a one-for-10 reverse stock split to regain compliance with Nasdaq's minimum average closing price requirement for continued listing.
The company said its common stock is expected to start trading on a split-adjusted basis on Nov. 2.
Tenon Medical shares fell past 22% in recent Wednesday trading.
Health care stocks were rising late Monday afternoon, with the NYSE Health Care Index adding 0.9% and the Health Care Select Sector SPDR Fund (XLV) up 0.7%.
The iShares Biotechnology ETF (IBB) was climbing 0.7%.
In corporate news, Pfizer and BioNTech said Monday the US Food and Drug Administration has approved its supplemental biologics license application for their updated COVID-19 vaccine targeting the Omicron XBB.1.5 sublineage for individuals 12 years of age and older. Pfizer shares were down 0.9% while BioNTech was shedding 1.9%.
Crinetics Pharmaceuticals shares jumped almost 62% after the company said a phase 3 trial of its paltusotine drug candidate for acromegaly, a hormonal disorder that causes swelling of the hands and feet, met its primary and secondary endpoints.
Zynex said Monday that its boar approved a $10 million stock-repurchase program that will begin Wednesday and end on Sept. 12, 2024, or when the $10 million limit is reached. Its shares added more than 8%.
Tenon Medical was down almost 40% after the company said it kicked off a public offering of its shares.
It’s time for another dive into the biggest pre-market stock movers as investors get ready to trade shares on Wednesday!
Moving stocks this morning are clinical trial data, public share offerings, an earnings report, and more.
Let’s get into this news below!
Pre-Market Stock Movers: 10 Top Gainers
10 Top Losers
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
More from InvestorPlace
White Label
Data API
Web Plug-ins
Poster Maker
Affiliate Program
The risk of loss in trading financial instruments such as stocks, FX, commodities, futures, bonds, ETFs and crypto can be substantial. You may sustain a total loss of the funds that you deposit with your broker. Therefore, you should carefully consider whether such trading is suitable for you in light of your circumstances and financial resources.
No decision to invest should be made without thoroughly conducting due diligence by yourself or consulting with your financial advisors. Our web content might not suit you since we don't know your financial conditions and investment needs. Our financial information might have latency or contain inaccuracy, so you should be fully responsible for any of your trading and investment decisions. The company will not be responsible for your capital loss.
Without getting permission from the website, you are not allowed to copy the website's graphics, texts, or trademarks. Intellectual property rights in the content or data incorporated into this website belong to its providers and exchange merchants.
Not Logged In
Log in to access more features

FastBull Membership
Not yet
Purchase
Log In
Sign Up